Incyte to Present at Upcoming Investor Conferences

WILMINGTON, Del.--()--Incyte (Nasdaq:INCY) announced today that it will present at the following investor conferences during the month of June:

  • Goldman Sachs 41st Annual Global Healthcare Conference (Virtual) on Tuesday, June 9, 2020 at 8:00 am (EDT);
  • JMP Securities Hematology & Oncology Forum (Virtual) on Thursday, June 18, 2020 at 4:40 pm (EDT); and
  • BMO Prescriptions for Success Healthcare Conference (Virtual) on Tuesday, June 23, 2020 at 1:30 pm (EDT)

The presentations will be webcast live and can be accessed at Investor.Incyte.com and will be available for replay for 30 days.

About Incyte

Incyte is a Wilmington, Delaware-based, global biopharmaceutical company focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of proprietary therapeutics. For additional information on Incyte, please visit Incyte.com and follow @Incyte.

Contacts

Incyte Contacts
Media
Catalina Loveman
+1 302 498 6171
cloveman@incyte.com

Investors
Michael Booth, DPhil
+1 302 498 5914
mbooth@incyte.com

Contacts

Incyte Contacts
Media
Catalina Loveman
+1 302 498 6171
cloveman@incyte.com

Investors
Michael Booth, DPhil
+1 302 498 5914
mbooth@incyte.com